Azopt

Brinzolamide Ophthalmic Suspension 1% (10 mg/mL): Carbonic Anhydrase Inhibitor for Glaucoma

Azopt Brinzolamide Ophthalmic Suspension is an Antiglaucoma agent containing the active ingredient Brinzolamide, a topical carbonic anhydrase inhibitor. While originally approved for human use, it is widely utilized in veterinary medicine on an extra-label basis for dogs, cats, and horses. Brinzolamide works by reducing the production of aqueous humor (the fluid inside the eye), which effectively lowers intraocular pressure (IOP). It is a primary treatment for managing glaucoma and ocular hypertension, helping to prevent the optic nerve damage and vision loss associated with these conditions.

Key Information

• Active Ingredient: Brinzolamide (10 mg/mL).

• Approved Species (Original Licensing): Human.

• Common Veterinary Species: Dog, Cat, and Horse (used extra-label).

• Uses: Antiglaucoma agent (to lower intraocular pressure).

• Form: Ophthalmic Suspension.

• Route of Administration: Ophthalmic (Eye Drops).

Prescription Required

Brinzolamide Ophthalmic Suspension is a prescription-only medication. A valid prescription from a licensed veterinarian is required for purchase. Professional oversight is critical because glaucoma is a progressive and often painful condition that requires precise monitoring of intraocular pressure to ensure the treatment is effective. Your veterinarian must also rule out contraindications, such as sulfa drug hypersensitivity (as Brinzolamide is a sulfonamide), and monitor for localized side effects like stinging or corneal irritation.